Acute liver failure in adults: An evidence-based management protocol for clinicians

Gastroenterology and Hepatology

Volumn 8, Issue 3, 2012, Pages

  Patton, Heather ^a,b   Misel, Michael ^b,c   Gish, Robert G ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute liver failure; Acute on chronic liver failure; Coagulopathy; Fulminant liver failure; Hepatic encephalopathy; Intracranial hypertension; Liver transplantation

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZOIC ACID; CHARCOAL; ENTECAVIR; FLUCONAZOLE; FRESH FROZEN PLASMA; GANCICLOVIR; HYDROCORTISONE; HYPERTENSIVE FACTOR; LACTULOSE; MANNITOL; NORADRENALIN; PARACETAMOL; PENICILLIN G; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; PROTON PUMP INHIBITOR; RIFAXIMIN; SILYMARIN; TENOFOVIR; UNINDEXED DRUG; VANCOMYCIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ACUTE LIVER FAILURE; ADULT DISEASE; AMMONIA BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; ANTICONVULSANT THERAPY; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BRAIN EDEMA; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG INDICATION; EVIDENCE BASED MEDICINE; FEVER; GLYCEMIC CONTROL; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HERPES SIMPLEX; HISTOPATHOLOGY; HUMAN; HYPERAMMONEMIA; HYPERCAPNIA; HYPOTENSION; HYPOXIA; INDUCED HYPOTHERMIA; INFECTION; INFECTION PREVENTION; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LABORATORY TEST; LIVER BIOPSY; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MEDICAL HISTORY; MULTIPLE ORGAN FAILURE; MUSHROOM POISONING; NUTRITIONAL SUPPORT; PATIENT MONITORING; PATIENT POSITIONING; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; SEDATION; SEIZURE; SINGLE DRUG DOSE; STRESS ULCER;

EID: 84859566461     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Devictor D, Tissieres P, Afanetti M, Debray D. Acute liver failure in children. Clin Res Hepatol Gastroenterol. 2011;35:430-437.
2. Squires RH Jr. Acute liver failure in children. Semin Liver Dis. 2008;28:153-166.
3. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282-298.
4. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197. (Pubitemid 40593928)
5. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995;21:240-252.
6. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954. (Pubitemid 35440240)
7. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-275. (Pubitemid 23224421)
8. O'Grady JG, Williams R. Classification of acute liver failure. Lancet. 1993;342:743.
9. Lee WM. Acute liver failure in the United States. Semin Liver Dis. 2003;23: 217-226. (Pubitemid 37052447)
10. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844-1852.
11. Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol. 2001;96:1968-1976. (Pubitemid 32660887)
12. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716-721. (Pubitemid 34183979)
13. Ware AJ, D'Agostino AN, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology. 1971;61:877-884.
14. Herrine S, Northrup B, Bell R. The effect of head elevation on cerebral perfusion pressure in fulminant hepatic failure. Hepatology. 1995;22:289A.
15. Mavrocordatos P, Bissonnette B, Ravussin P. Effects of neck position and head elevation on intracranial pressure in anaesthetized neurosurgical patients: preliminary results. J Neurosurg Anesthesiol. 2000;12:10-14. (Pubitemid 30040835)
16. Munoz SJ, Robinson M, Northrup B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology. 1991;13:209-212.
17. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16:1-7.
18. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157-158. (Pubitemid 23029318)
19. Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2011;127:1338-1346.
20. Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med. 2010;36:210-213.
21. Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034-2039. (Pubitemid 36793288)
22. Jalan R, Damink SW, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999;354:1164-1168. (Pubitemid 29460446)
23. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma. 2009;67:202-208.
24. Heinius G, Hahn RG, Sonden A. Hypothermia increases rebleeding during uncontrolled hemorrhage in the rat. Shock. 2011;36:60-66.
25. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients-a randomized clinical trial [ISRCTN62699180]. Crit Care. 2005;9:R530-R540.
26. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196-202. (Pubitemid 40116557)
27. Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma. 2000;17:41-51. (Pubitemid 30075615)
28. Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res. 1999;21:758-764.
29. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39:464-470. (Pubitemid 38222187)
30. Rhoney DH, Parker D. Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology. Neurol Res. 2001;23:237-259. (Pubitemid 32290911)
31. Citerio G, Cormio M. Sedation in neurointensive care: advances in understanding and practice. Curr Opin Crit Care. 2003;9:120-126. (Pubitemid 36408130)
32. Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220-1222. (Pubitemid 34665322)
33. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology. 2000;32:536-541.
34. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol. 2004;41:89-96. (Pubitemid 39005158)
35. Bonnet F, Richard C, Glaser P, Lafay M, Guesde R. Changes in hepatic flow induced by continuous positive pressure ventilation in critically ill patients. Crit Care Med. 1982;10:703-705.
36. McGuire G, Crossley D, Richards J, Wong D. Effects of varying levels of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure. Crit Care Med. 1997;25:1059-1062. (Pubitemid 27264253)
37. Steiner LA, Johnston AJ, Czosnyka M, et al. Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients. Crit Care Med. 2004;32:1049-1054. (Pubitemid 38471529)
38. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
39. Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71-77. (Pubitemid 37265777)
40. Holmes CL. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care. 2005;11:413-417. (Pubitemid 41482695)
41. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003;31:1659-1667. (Pubitemid 36714218)
42. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16:389-402. (Pubitemid 27074781)
43. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology. 1993;17:196-201. (Pubitemid 23046688)
44. Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755-764. (Pubitemid 37070693)
45. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734-739.
46. Gazzard BG, Clark R, Borirakchanyavat V, Williams R. A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut. 1974;15:89-93.
47. Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129-136.
48. Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010;42:2590-2593.
49. Gazzard BG, Henderson JM, Williams R. Factor VII levels as a guide to prognosis in fulminant hepatic failure. Gut. 1976;17:489-491.
50. Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617-620.
51. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138-143. (Pubitemid 36204564)
52. Macdougall BR, Williams R. H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure: a controlled trial. Gastroenterology. 1978;74:464-465. (Pubitemid 8276599)
53. Asfaha S, Almansori M, Qarni U, Gutfreund KS. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease. J Clin Apher. 2007;22:295-298. (Pubitemid 350013066)
54. Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033-1040. (Pubitemid 9061211)
55. Vanholder R. Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish? Crit Care. 2011;15:204.
56. Davenport A, Bramley PN. Cerebral function analyzing monitor and visual evoked potentials as a noninvasive method of detecting cerebral dysfunction in patients with acute hepatic and renal failure treated with intermittent machine hemofiltration. Ren Fail. 1993;15:515-522. (Pubitemid 23268179)
57. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl. 1993;41:S245-S251.
58. Davenport A. Renal replacement therapy for patients with acute liver failure awaiting orthotopic hepatic transplantation. Nephron. 1991;59:315-316.
59. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001;37:457-466. (Pubitemid 32195283)
60. Davenport A. Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy. Contrib Nephrol. 2001;132:313-322.
61. Mehta RL. Continuous renal replacement therapy in the critically ill patient. Kidney Int. 2005;67:781-795. (Pubitemid 40139878)
62. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340:1723-1731. (Pubitemid 29252600)
63. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190-201.
64. Izumi S, Langley PG, Wendon J, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology. 1996;23:1507-1511. (Pubitemid 26181234)
65. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002;359:558-563. (Pubitemid 34178437)
66. Smilkstein MJ, Douglas DR, Daya MR. Acetaminophen poisoning and liver function. N Engl J Med. 1994;331:1310-1311.
67. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557-1562. (Pubitemid 19003420)
68. Buckley NA, Whyte IM, O'Connell DL, Dawson AH. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol Clin Toxicol. 1999;37:759-767.
69. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303:1026-1029.
70. Broussard CN, Aggarwal A, Lacey SR, et al. Mushroom poisoning-from diarrhea to liver transplantation. Am J Gastroenterol. 2001;96:3195-3198. (Pubitemid 33095364)
71. Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455-462. (Pubitemid 9077614)
72. Peters DJ, Greene WH, Ruggiero F, McGarrity TJ. Herpes simplexinduced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci. 2000;45:2399-2404. (Pubitemid 32198642)
73. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625-631. (Pubitemid 38834047)
74. Mabie WC. Acute fatty liver of pregnancy. Crit Care Clin. 1991;7:799-808.
75. Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389-395. (Pubitemid 29409920)
76. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439-445. (Pubitemid 19192181)
77. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648-651. (Pubitemid 16038182)
78. Bernuau J, Samuel D, Durand F, Saliba F, Bourlier M, Adam R. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology. 1991;14:49A.
79. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut. 1992;33:98-102.
80. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370-1376.
81. Takahashi Y, Kumada H, Shimizu M, et al. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology. 1994;19:1065-1071. (Pubitemid 24134226)
82. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology. 2002;36:659-665. (Pubitemid 34977176)
83. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29:648-653. (Pubitemid 29109575)
84. Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med. 1998;26:279-284. (Pubitemid 28082689)
85. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789-796. (Pubitemid 46450630)
86. Kremers WK, Van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764-769.
87. Hadem J, Stiefel P, Bahr MJ, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339-345. (Pubitemid 351318381)